Latest Product Updates and Feature Enhancements on Veeva CRM
New Veeva Vault CTMS to Transform Clinical Operations as the Industrys First Unified Cloud Solution
Veeva Systems has introduced Veeva Vault CTMS, the first cloud-based application unifying CTMS and eTMF for clinical operations. This solution offers life sciences companies a single source for clini...cal data, real-time visibility, and seamless stakeholder collaboration. Vault CTMS, part of the Veeva Vault Clinical Suite, aims to streamline clinical trial processes and is expected to be available in Q1 2017.
Veeva Introduces New ePRO Application for Faster Access to Patient Data
Veeva Systems has launched Veeva ePRO, a new application designed to enhance patient-reported outcomes in digital clinical trials. This tool allows patients to complete assessments via mobile or web,... providing real-time data access for sponsors and research sites. Part of the Veeva Vault Clinical Suite, ePRO aims to streamline trial activities and improve patient retention by addressing common challenges in clinical trials.
Veeva Reinvents Clinical Data Management with a Single Application to Manage All Trial Data
Veeva Systems has launched Veeva Vault CDMS, a next-generation cloud application designed to streamline clinical data management. This single application integrates coding, EDC, data cleaning, and re...porting, allowing life sciences companies to manage all trial data efficiently. Vault CDMS aims to replace multiple tools, providing a complete view of clinical data for faster insights and execution. It is part of the Veeva Vault Clinical Suite, enhancing trial processes on a unified cloud platform.
Veeva announces Falcon, agentic platform for drug development
Veeva Systems has launched Falcon, a new agentic platform designed to enhance drug development processes. This platform aims to streamline operations and improve efficiency in the life sciences indus...try.
Veeva Announces Falcon, an Agentic Platform and Standard Agents to Deliver ...
Veeva Systems has introduced Falcon, an agentic platform designed to enhance life sciences operations. The platform includes standard agents to streamline processes and improve efficiency. This launc...h underscores Veeva's commitment to providing innovative solutions tailored to the life sciences industry.
Veeva Introduces Falcon Agentic Platform, Secures Teva's Global Vault ...
Veeva Systems has launched the Falcon Agentic Platform, an AI-driven solution integrated with its Development Cloud to streamline clinical, regulatory, and safety workflows. The platform aims to redu...ce costs and accelerate drug development, with early access available in November 2026. Additionally, Teva Pharmaceuticals will globally deploy Veeva Vault CRM, enhancing commercial operations with AI-driven insights.
Veeva Launches Falcon AI Platform to Automate Drug Development Processes
Veeva Systems has launched Falcon, an AI-driven platform to automate drug development processes, focusing on trial master file document intake, health authority correspondence, and safety case triage.... Available for early adopters in November 2026, Falcon aims to reduce costs, increase speed, and ensure compliance for biopharmaceutical companies, positioning Veeva as a leader in AI solutions for life sciences.
Veeva Launches Falcon Platform to Enhance Drug Development Efficiency
Veeva Systems has introduced the Falcon platform to enhance drug development efficiency for biopharma companies. The platform integrates with Veeva Development Cloud applications to reduce costs and ...speed up processes, focusing on trial master file document intake, quality control, regulatory correspondence, and safety case triage. Falcon is part of Veeva AI and will be available to early adopters in November 2026, reinforcing Veeva's leadership in life sciences.
Veeva Systems Launching Agentic Platform for Drug Development Projects
Veeva Systems has introduced the Agentic platform, designed to enhance drug development projects. This new platform aims to streamline processes and improve efficiency in the life sciences industry.
Veeva Systems' RTSM Momentum Signals Another Long-Term Growth Driver ...
Veeva Systems is gaining momentum in the randomization and trial supply management (RTSM) market, becoming a key growth driver for its R&D business. A major pharma win highlights customer confidence ...in Veeva's clinical ecosystem. The RTSM platform, alongside EDC and eCOA, presents a multibillion-dollar opportunity, with a focus on expanding CRO partnerships to enhance its Development Cloud platform.
Veeva Systems showcases key features of Veeva CDB, including the Study Dashboard, Dynamic Queries, and Automated Protocol Deviations. These tools enhance risk-based review and automate data workflows..., improving data quality and speed in clinical trials.
Veeva Systems introduces the Veeva Clinical Operations Global Directory, part of its Clinical Operations Suite. This tool aims to replace Excel trackers and facilitate document reuse, enhancing trial... efficiency and accelerating study timelines.
Veeva Systems Expands AI and Vault CRM Momentum: Time to ...
Veeva Systems is expanding its AI and Vault CRM capabilities, driving momentum in the life sciences sector. The company is enhancing its AI strategy through partnerships with BioMarin and Roche and a...cquiring Ostro, an AI engagement platform. Veeva's Vault CRM adoption is growing, with 140 customers live, including top pharmaceutical firms. However, AI monetization and CRM transition challenges persist.
Veeva Systems introduces the Business Rules Engine in Veeva Vault CRM Events Management, enhancing compliance for pharma events. This tool automates processes like expense estimates and speaker rules..., reducing compliance risks. It offers configurable rule sets for attendee requirements and event materials, ensuring accurate event planning and execution.
Veeva Systems' Submissions Archive is a secure global repository for regulatory submissions, offering dynamic search, filtering, and navigation. It supports all electronic and paper formats, providin...g a comprehensive view of submissions and health authority interactions. The platform is trusted by over 400 biopharma companies for its efficiency in regulatory processes and global readiness.
Microsoft Teams and Outlook Integrations with Veeva Vault CRM
Veeva Systems has integrated Microsoft Teams and Outlook with its Veeva Vault CRM, enhancing meeting coordination and scheduling for biopharma teams. This integration allows users to synchronize cale...ndars, conduct video meetings, and manage schedules efficiently, leveraging Veeva's CRM capabilities alongside Microsoft's productivity tools.
Veeva Systems introduces Veeva Commercial Insights, a tool designed to connect field insights with commercial decision-makers. This solution uses AI and human input to tag insights and identify comme...rcial themes, which are then shared with leaders via a web app. It aims to enhance decision-making and will be available to early adopters in 2026.
Veeva Announces MyVeeva to Enable Patient-Centric Clinical Trials
Veeva Systems has introduced MyVeeva for Patients, a new application designed to facilitate patient-centric and paperless clinical trials. The application supports virtual visits, ePRO, eConsent, and... eSource capabilities, allowing for remote collaboration between patients, doctors, and clinical research coordinators. MyVeeva integrates with Veeva SiteVault and is set to be available in December 2020.
Veeva Introduces New Application to Speed Payments to Clinical Research Sites
Veeva Systems has launched Veeva Vault Payments, a new application for its Vault CTMS, to streamline payments to clinical research sites. This add-on automates payment tracking, providing sponsors an...d CROs with enhanced financial visibility and accuracy. Vault Payments integrates with existing workflows, enabling faster and more transparent payments, and is already being implemented by three early adopters.
Veeva Announces Vault Site Connect to Automate Information Sharing in Clinical Trials
Veeva Systems launched Veeva Vault Site Connect, a new application that automates information sharing between sponsors and clinical research sites, enhancing collaboration and speeding up clinical tr...ials. This application integrates with Veeva's existing Vault Clinical applications and SiteVault, improving processes like feasibility studies, document exchange, and patient status updates, ultimately reducing administrative tasks and improving study quality.
Veeva Systems has integrated WhatsApp Business into its Vault CRM Engage platform, enhancing omnichannel engagement for biopharma companies. This integration allows field teams to use WhatsApp for co...mpliant, personalized communication with healthcare professionals (HCPs), ensuring adherence to Meta's rules and offering flexibility in communication channels. The addition aims to balance convenience and compliance, addressing HCP preferences for efficient, tailored interactions.
Veeva Systems introduces Veeva LIMS, a cloud-based application designed to modernize quality control for virtual biopharma companies. The solution integrates QC data management, enhances stability st...udy management, and supports GMP compliance. It aims to streamline processes, reduce errors, and improve inspection readiness, facilitating efficient product development and commercial launch.
Veeva Systems Inc. (VEEV) Launches eSource to Streamline Clinical Trial ...
Veeva Systems Inc. has launched Veeva eSource, a new application within its SiteVault platform, aimed at enhancing clinical trial data management. This tool facilitates direct digital data capture at... research sites, integrates with electronic health records, and automates data flow to sponsors, reducing manual operations and errors. Veeva eSource will be available to early adopters in the latter half of 2026.
Veeva Systems introduces an automated training workflow to enhance collaboration between sponsors and site teams. This solution streamlines training processes, reduces redundant tasks, and eliminates... manual data entry, ensuring site staff receive role-specific training.
Veeva Systems Inc. (VEEV): Balancing Analyst Skepticism with Innovation ...
Veeva Systems has launched Veeva eSource, a new Veeva SiteVault aimed at enhancing clinical trial efficiency and data quality. Additionally, Veeva has expanded its long-term enterprise agreement with... BioMarin Pharmaceutical to improve healthcare provider and patient experiences through Veeva's technology, supporting BioMarin's digital transformation and mission to deliver innovative therapies.
Veeva Announces eSource Application for Research Sites to Eliminate Paper and Streamline Clinical Trial Data Flow - Software - Zinc Ahead Ltd | Veeva Systems
Veeva Systems has announced the launch of Veeva eSource, a new application designed to enhance clinical trial data management by eliminating paper processes and integrating Electronic Health Records ...(EHR) with Electronic Data Capture (EDC) systems. This innovation aims to improve data quality and streamline clinical trials by automating data flow and reducing manual data entry, ultimately benefiting research sites and sponsors.
Veeva Announces eSource Application for Research Sites to Eliminate Paper and Streamline Clinical Trial Data Flow
Veeva Systems has announced Veeva eSource, a new application within the Veeva SiteVault platform, designed to eliminate paper use and streamline clinical trial data flow through EDC integration and E...HR to EDC transfer. This innovation aims to enhance data quality and efficiency for research sites, with early adopter availability planned for the second half of 2026.
Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing - PR Newswire
Veeva Systems announced the launch of Veeva Environmental Monitoring, a cloud-native solution integrated with Veeva LIMS, to enhance quality control in manufacturing. This application will automate e...nvironmental sample collection and analysis, ensuring compliance with GMP standards and optimizing batch release processes. The solution will be available in December 2026.
Veeva AI Agents Now Available to Increase Productivity and Customer ...
Veeva Systems has launched Veeva AI Agents for Vault CRM and PromoMats, enhancing productivity and customer engagement in the life sciences sector. These AI agents, including Free Text Agent and Voic...e Agent, offer features like call note accuracy and voice input. Additional agents for various applications are planned for 2026, aiming to transform industry workflows.
Veeva Systems introduces Veeva Link Key People, a feature that consolidates comprehensive data on medical and scientific experts to enhance engagement and drive value-driven interactions. It offers d...eep insights across therapeutic areas, network analysis, and compliance with privacy laws. The feature integrates seamlessly with Veeva products, providing tailored information for medical and commercial teams.
Veeva Systems enhances its OpenData product, offering high-quality, integrated customer reference data for improved commercial agility. The product features seamless integration with Vault CRM, fast ...data change request resolution, and robust compliance data. It supports global availability across 100+ countries, expanding to 115+ in 2024, and includes verified HCP emails as an add-on.
Veeva Expands Basics Suite as Over 100 Biotechs Adopt Platform for Scalable Growth
Veeva Systems has expanded its Basics Suite, a platform designed to support scalable growth, which has been adopted by over 100 biotech companies. This expansion aims to enhance the platform's capabi...lities, providing biotech firms with improved tools for growth and scalability.
Veeva Batch Release | Batch Release Software for Biopharma
Veeva Systems has introduced the Veeva Batch Release, an end-to-end software solution for the biopharma industry. This tool automates the aggregation, review, and traceability of batch-related data, ...integrating with systems like QMS, LIMS, ERP, and RIM. It aims to accelerate GMP release and market-ship decisions, enhancing efficiency and accuracy while reducing costs.
Strategic Partnerships and Integrations of Veeva CRM
Lotus Clinical Research Expands Partnership with Veeva to Accelerate Clinical Trials
Lotus Clinical Research has expanded its partnership with Veeva Systems by broadening its use of the Veeva Vault Clinical Suite. This strategic move enhances Lotus' clinical trial operations, reducin...g startup times and improving coordination with sponsors and sites. Veeva's integrated clinical applications support Lotus' growth and diversification in clinical research.
Veeva Systems Partnerships Deepen Role As Core Life Sciences Cloud Platform
Veeva Systems has formed strategic partnerships with Smith+Nephew and Snowflake. Smith+Nephew will standardize its global quality management on Veeva Quality Cloud, while the Snowflake partnership wi...ll connect Veeva Vault Platform with Snowflake's AI Data Cloud. These collaborations deepen Veeva's role in life sciences workflows, enhancing its position as core infrastructure for quality and analytics.
Veeva Systems Strengthens Its Life Sciences Data Moat with Snowflake ...
Veeva Systems has partnered with Snowflake to integrate the Snowflake AI Data Cloud with the Veeva Vault Platform. This collaboration enhances Veeva's data capabilities, allowing life sciences organi...zations to use Veeva data for analytics and AI without moving core regulated data. The partnership supports Veeva's strategy to improve data management and interoperability, reinforcing its position in the life sciences data market.
Snowflake and Veeva Systems have partnered to integrate AI capabilities in the life sciences sector. This collaboration connects Snowflake's AI Data Cloud with Veeva Vault, enabling seamless data int...egration for enhanced analytics and AI applications. The partnership aims to improve clinical trials, regulatory compliance, and commercial operations by providing rapid, cross-functional insights and automating data pipelines for better compliance and operational efficiency.
Veeva and OpenEvidence form long-term AI partnership to accelerate ...
Veeva Systems and OpenEvidence have formed a long-term partnership to co-develop Open Vista, an AI platform designed to enhance clinical trial access and accelerate drug discovery. This collaboration... will leverage Veeva's life sciences data with OpenEvidence's AI technology to improve patient access and understanding of medical needs. The first products are expected in 2026.
LEO Pharma Leverages Veeva Link for Key People to Expand Engagement with Scientific Experts
LEO Pharma expands its partnership with Veeva Systems by leveraging Veeva Link for Key People to enhance engagement with scientific experts in dermatology. This integration aims to improve LEO Pharma...'s medical and sales teams' interactions with the scientific community, supporting the development of new treatments and advancing patient care.
RegASK & Veeva Systems Partner to Boost RIM Intelligence Capabilities
Veeva Systems has partnered with RegASK to enhance its Regulatory Information Management (RIM) capabilities. This collaboration integrates RegASK's AI-driven regulatory intelligence with Veeva's comp...liance systems, providing life sciences companies with real-time regulatory insights. The partnership aims to improve decision-making, compliance outcomes, and product approvals, strengthening Veeva's position in the life sciences software market.
UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials
Veeva Systems and UCB have partnered to enhance patient experiences in clinical trials through digital solutions. UCB will adopt Veeva's ePRO and eConsent applications to streamline patient-reported ...outcomes and consent processes. This collaboration aims to set a new standard for digital clinical trials, leveraging Veeva's technology to improve trial efficiency and accessibility.
Veeva RegASK Alliance Links AI Compliance Push With Discounted ...
Veeva Systems has partnered with RegASK to integrate AI-driven regulatory intelligence into its Regulatory Information Management (RIM) platform. This collaboration aims to enhance compliance workflo...ws for life sciences companies by connecting real-time regulatory signals to Veevas RIM offering. The integration focuses on improving response times to regulatory changes, emphasizing Veeva's role in AI-driven compliance support.
RegASK & Veeva Systems Partner to Boost RIM Intelligence Capabilities
Veeva Systems has partnered with RegASK to enhance its Regulatory Information Management (RIM) capabilities. This collaboration integrates RegASKs AI-driven regulatory intelligence with Veeva's compl...iance systems, enabling life sciences companies to access real-time regulatory insights. The partnership aims to improve decision-making, compliance outcomes, and product approvals, strengthening Veeva's position in the life sciences software market.
RegASK Joins Veeva AI Partner Program, Connecting Agentic Regulatory Intelligence with ...
RegASK has joined the Veeva AI Partner Program to integrate its regulatory intelligence platform with Veeva's Regulatory Information Management (RIM) system. This partnership aims to enhance life sci...ences organizations' ability to align regulatory intelligence with compliance systems, enabling faster regulatory decisions. The collaboration reflects a strategic shift in the life sciences industry towards proactive regulatory management.
Veeva Systems Expands Long-Term Partnership With BioMarin Pharmaceutical - Nasdaq
Veeva Systems and BioMarin Pharmaceutical have extended their long-term partnership. The expanded agreement aims to enhance BioMarin's operational efficiency and patient experience by utilizing Veeva...'s software, data, services, and consulting. This strategic collaboration supports BioMarin's efforts to advance new medicines globally.
Veeva and BioMarin Form Long-Term Strategic Partnership - Investing News Network
Veeva Systems and BioMarin Pharmaceutical have entered a long-term strategic partnership to enhance BioMarin's speed and efficiency in developing and commercializing therapies. This collaboration wil...l leverage Veeva's software, data, and consulting services to optimize BioMarin's operations and patient experience. The partnership aims to combine BioMarin's scientific capabilities with Veeva's technological expertise to accelerate the delivery of transformative medicines.
Veeva Announces Expanded Partnership with Roche - Software - Zinc Ahead Ltd | Veeva Systems
Veeva Systems has expanded its partnership with Roche Pharmaceuticals, which will now adopt Veeva Vault CRM. This move aims to enhance Roche's global Pharma operations with AI-enabled CRM capabilitie...s, offering personalized interactions and insights for healthcare professionals. Veeva AI agents, including Free Text Agent and Voice Agent, will be available in December 2025.
Mergers, Acquisitions, and Business Moves by Veeva CRM
Veeva Systems Acquires Ostro As AI Tools Meet Depressed Share Price
Veeva Systems has acquired Ostro, an AI-powered brand engagement platform for life sciences, which will operate independently while enhancing Veeva's digital engagement capabilities. This acquisition... aims to strengthen Veeva's offerings in patient and doctor communication within the life sciences sector.
The Trusted Source: How Veevas Acquisition of Ostro is Rewriting How Patients and Doctors Get Drug Information
Veeva Systems acquired Ostro, an AI-powered brand engagement platform, for $100 million to enhance direct communication between patients and healthcare professionals (HCPs). This acquisition aligns w...ith Veeva's strategy to integrate AI into its Vault platform, aiming to improve patient and HCP engagement by providing accurate, approved medical information. The move differentiates Veeva from horizontal platforms like Salesforce by focusing on industry-specific solutions for life sciences.
Veeva Acquires Ostro and its AI Chat Tool for Pharma Brand Engagement
Veeva Systems has acquired Ostro, an AI chat tool developer, for $100 million. Ostro's platform provides pharma companies with compliant drug information and engagement analytics. Post-acquisition, O...stro will remain independent but will integrate with Veeva's cloud software to enhance patient and doctor interactions.
Veeva Systems (VEEV) Announces Acquisition of Ostro
Veeva Systems has acquired Ostro for approximately $100 million. Ostro will operate as an independent unit under CEO Chase Feiger. The acquisition aims to integrate Ostro's brand engagement platform ...with Veeva's Commercial Cloud applications, enhancing workflows in life sciences. Ostro's AI-led chat experience provides compliant answers to patients and doctors, supporting faster access to accurate information.
Veeva Systems (VEEV) Announces Acquisition of Ostro
Veeva Systems announced the acquisition of Ostro for approximately $100 million. Ostro, a brand engagement platform in life sciences, will operate independently under CEO Chase Feiger. The acquisitio...n aims to integrate Ostro with Veeva's Commercial Cloud applications to enhance customer-centric workflows.
Veeva Acquires Ostro to Expand AI-Powered Engagement in Life Sciences
Veeva Systems has acquired Ostro, an AI-powered brand engagement platform for the life sciences industry, for approximately $100 million. This acquisition aims to enhance Veeva's Commercial Cloud by ...integrating Ostro's conversational AI capabilities, enabling pharmaceutical companies to provide real-time, compliant responses to healthcare professionals and patients. The move is expected to strengthen Veeva's position in AI-driven customer engagement and support long-term growth.
Veeva Systems Buys Ostro As AI Deal Undervalues Share Price
Veeva Systems has acquired Ostro, a platform specializing in AI-driven, compliant communications for life sciences. This acquisition enhances Veeva's commercial offerings by integrating AI tools for ...personalized engagement with healthcare professionals and patients. The move aims to strengthen Veeva's position in the life sciences sector, focusing on compliant digital interactions.
Veeva Systems Acquires Ostro for $100 Million to Boost AI-Driven Pharma ...
Veeva Systems has acquired Ostro, a brand engagement platform for life sciences, for $100 million. Ostro's AI-driven chat technology will integrate with Veeva Commercial Cloud, enhancing pharma brand... engagement. The acquisition, set to close in Q2 2026, will see Ostro operate independently under CEO Chase Feiger.
Veeva Acquires Ostro the Leading Brand Engagement Platform for Life Sciences
Veeva Systems has acquired Ostro, a leading brand engagement platform for life sciences, for approximately $100 million. Ostro provides AI-driven, compliant chat experiences for patients and doctors,... enhancing brand engagement and insights. The acquisition aims to integrate Ostro with Veeva's Commercial Cloud applications, improving customer engagement workflows. Ostro will operate independently under CEO Chase Feiger.
Veeva Acquires Ostro to Complete Its Pharma Commercial Stack
Veeva Systems has acquired Ostro, an AI-driven brand engagement platform for life sciences, for $100 million. This acquisition enhances Veeva's commercial software portfolio by adding a patient- and ...physician-facing engagement layer. Ostro's platform uses conversational AI to provide drug information, integrating with Veeva's CRM. The acquisition aims to create a unified commercial cloud, linking digital engagement with field activities.
Veeva Systems has acquired Ostro, a brand engagement firm, for $100 million. Ostro's AI-powered tools, which aid pharma companies in engaging with doctors and patients, will integrate with Veeva's Co...mmercial Cloud. This acquisition enhances Veeva's offerings in the life sciences sector, following its recent purchase of Yonalink for clinical trial management.
Veeva pays $100M for Ostro and its pharma-focused AI chat tool
Veeva Systems has acquired Ostro, a company specializing in AI chat tools for the pharmaceutical industry, for $100 million. This acquisition aims to enhance Veeva's offerings in the life sciences se...ctor by integrating advanced AI capabilities.
Veeva acquiert Ostro, la principale plateforme d'engagement des marques ...
Veeva Systems has acquired Ostro, a leading brand engagement platform for life sciences, for approximately $100 million. Ostro, which uses AI to provide compliant and immediate responses to patients ...and physicians, will operate as an independent unit under CEO Chase Feiger. Veeva plans to integrate Ostro with its Commercial Cloud applications to enhance customer engagement.
Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life ...
Veeva Systems has acquired Ostro, a leading AI-driven brand engagement platform for life sciences, for $100 million. Ostro enhances patient and doctor interactions with compliant, real-time responses.... It will operate independently, integrating with Veeva's Commercial Cloud to improve customer engagement. This acquisition aims to expand Veeva's AI capabilities in the life sciences sector.
Veeva Systems has acquired Ostro, a leading AI-driven brand interaction platform for life sciences, for approximately $100 million. Ostro will operate independently, led by CEO Chase Feiger, and will... eventually integrate with Veeva's Commercial Cloud applications to enhance customer interactions. This acquisition aims to improve access to accurate information for patients and doctors, leveraging Ostro's compliance-focused AI technology.
Veeva adquire a Ostro, a principal plataforma de engajamento de marcas ...
Veeva Systems has acquired Ostro, a leading AI-driven brand engagement platform for life sciences, for approximately $100 million. Ostro will operate independently, focusing on seamless integrations ...with Veeva's Commercial Cloud to enhance customer engagement. The acquisition aims to provide instant, compliant information access for patients and physicians, leveraging Ostro's conversational AI and semantic search capabilities.
Veeva Systems is acquiring AI firm Ostro for $100 million to enhance its AI capabilities for healthcare providers. Ostro will operate independently, focusing on integrating AI-driven workflows that e...nable direct digital engagement between pharma brands and healthcare providers. This acquisition aims to scale regulated, AI-driven engagement in the life sciences sector.
Veeva Systems acquires Ostro for approximately $100 million
Veeva Systems has acquired Ostro, a brand engagement platform for life sciences, for $100 million. Ostro's AI-driven chat technology will enhance Veeva's offerings by providing compliant, real-time m...edical information on brand websites. Ostro will remain independent under CEO Chase Feiger, focusing on integrating with Veeva's Commercial Cloud applications.
Veeva acquiert Ostro, la principale plateforme d'engagement des marques ...
Veeva Systems has acquired Ostro, a leading brand engagement platform for life sciences, for approximately $100 million. Ostro will operate as an independent unit, led by CEO Chase Feiger, and will i...ntegrate with Veeva's Commercial Cloud applications to enhance customer engagement. Ostro's AI-driven platform provides compliant, real-time information to patients and doctors, improving brand reach and engagement.
Veeva Acquires AI Chat Platform Ostro for $100 Million
Veeva Systems has acquired AI chat platform Ostro for $100 million to enhance life sciences customer engagement. Ostro's technology provides real-time, compliant answers from medically reviewed mater...ials, improving patient and doctor interactions. The acquisition aligns with Veeva's vision to integrate AI into its Commercial Cloud applications, aiming for a unified, customer-centric model in the healthcare industry.
Veeva acquires Ostro for $100M: AI engagement expansion
Veeva Systems has acquired Ostro, a brand engagement platform for the life sciences industry, for $100 million. This acquisition aims to enhance Veeva's AI and automation capabilities within its clin...ical and commercial ecosystems. Ostro will operate independently, led by CEO Chase Feiger, and will continue to provide AI-driven, MLR-compliant responses to medical queries.
Veeva Systems Acquires Ostro for $100M to Enhance AI Customer ...
Veeva Systems has acquired Ostro for $100 million to enhance its AI-driven customer engagement capabilities in the healthcare sector. Ostro, known for its AI-powered tools, will initially operate ind...ependently under CEO Chase Feiger before integrating with Veeva's Commercial Cloud applications. This acquisition aims to improve brand engagement and strengthen Veeva's position in the AI customer engagement market.
Funding News and Financial Performance of Veeva CRM
Veeva Systems Corrects Financial Outlook, Adjusts Revenue and Earnings Projections
Veeva Systems corrected its financial outlook due to inaccuracies in prior reports. The company adjusted its revenue and earnings projections to provide a more accurate view of its anticipated financ...ial performance. Veeva is implementing stricter verification processes for future communications to prevent similar errors.
Veeva to Release Fiscal 2027 First Quarter Results on June 3, 2026
Veeva Systems will announce its fiscal 2027 first quarter financial results on June 3, 2026. The company will host a conference call and webcast to discuss the results.
Veeva Systems Surpasses $3 Billion Revenue Milestone for Fiscal Year 2026
Veeva Systems achieved a significant milestone by surpassing $3 billion in revenue for fiscal year 2026, reaching $3.195 billion. The company recorded $836 million in the fourth quarter, driven by a ...16% increase in subscription revenue. Veeva's non-GAAP EPS was $2.06, exceeding expectations, with a 43.8% operating margin and $1.39 billion in operating cash flow.
Veeva to join S&P 500 as Coterra exits after Devon deal
Veeva Systems will be added to the S&P 500 index, replacing Coterra Energy following its acquisition by Devon Energy. This inclusion signifies Veeva's growing influence and recognition in the market.
Dear Veeva Systems Stock Fans, Mark Your Calendar for May 7
Veeva Systems will join the S&P 500 Index on May 7, 2026, replacing Coterra Energy. This inclusion is expected to boost Veeva's visibility and attract significant institutional investment, enhancing ...its role in the pharmaceutical and biotechnology sectors. The company recently reported strong financial results and announced a $2 billion share repurchase program.
Veeva Systems will join the S&P 500 index on May 7, replacing Coterra Energy. This inclusion is expected to attract more fund managers to purchase Veeva's shares, potentially boosting its stock price.... Veeva reported a quarterly profit of $244 million on $836 million in revenue, reflecting a 16% year-over-year growth, driven by strong sales in its cloud software for the life sciences sector.
Veeva Systems Stock Beats Q4 Guidance With $836M Revenue and $3.2B Full ...
Veeva Systems reported Q4 FY2026 revenue of $836 million, surpassing guidance and achieving a full-year revenue of $3.195 billion. The R&D Cloud was a key growth driver, with notable wins in the phar...maceutical sector. Veeva guided for 13% subscription revenue growth in FY2027, focusing on early-stage, high-growth products. The company continues to expand its Vault CRM platform among top pharmaceutical companies.
Veeva Systems (VEEV) Q4 Fiscal 2026 Earnings Recap: Beats Estimates on ...
Veeva Systems reported Q4 fiscal 2026 revenues of $836 million, surpassing estimates and reflecting a 16% year-over-year growth. Non-GAAP EPS was $2.06, exceeding expectations. The company projects F...Y2027 revenues of $3.585-$3.600 billion, driven by subscription services and AI initiatives. Veeva's robust performance underscores its competitive position in life sciences cloud solutions.
Veeva Systems (VEEV) Reiterated Confidence in Achieving Its 2030 Financial Targets
Veeva Systems reiterated its confidence in achieving its 2030 financial targets despite competitive pressures in the CRM market, particularly from Salesforce. The company highlighted strong fiscal th...ird-quarter results and issued guidance above market expectations. However, concerns over lower-than-expected Vault CRM customer growth led to a 25% stock sell-off.
Veeva Systems reported strong Q4 results for 2026, surpassing market expectations. Despite a cautious outlook, analysts maintain a positive sentiment, with over 70% holding a bullish view. The compan...y's integrated platform offers a competitive edge, and its guidance reflects customer planning cycles. Analysts have adjusted price targets, citing software multiple compressions, but continue to rate Veeva as a Buy.
Veeva Systems Reports Strong Q4 Results, Exceeds Market Expectations
Veeva Systems reported strong Q4 financial results, surpassing market expectations with $836 million in revenue. The company's growth was driven by increased demand for system updates in safety and R...&D, and an expanded client base among major pharmaceutical firms. Adjusted earnings per share reached $2.06, and the operating margin improved from the previous year.
Veeva Systems Exceeds Q4 Fiscal 2026 Expectations with Strong Revenue Growth
Veeva Systems reported Q4 fiscal 2026 revenue of $836 million, surpassing expectations and highlighting strong market demand. The company achieved a total revenue of $3.195 billion for the fiscal yea...r, exceeding its $3 billion goal. Veeva's strategic partnerships and increased customer migration to its Vault CRM system contributed to this growth. The company plans to focus on AI integration for future product development.
Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates
Veeva Systems reported strong Q4 fiscal 2026 results, with adjusted EPS of $2.06 and revenues of $836 million, both surpassing estimates. The company saw significant growth in its Subscription servic...es and Professional services segments. Veeva also provided optimistic guidance for fiscal 2027, expecting revenues between $3,585 million and $3,600 million and continued expansion of its AI capabilities and customer base.
Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates
Veeva Systems reported strong Q4 fiscal 2026 results, with adjusted EPS of $2.06 and revenues of $836 million, both surpassing estimates. The company's subscription services and professional services... segments showed significant growth. Veeva also provided optimistic guidance for fiscal 2027, expecting revenues between $3.585 billion and $3.6 billion. The company continues to expand its AI capabilities and customer base in the life sciences sector.
(VEEV) Veeva Systems Expects Fiscal 2027 Adjusted EPS of About $8.85
Veeva Systems anticipates an adjusted EPS of approximately $8.85 for fiscal 2027. The company also projects its fiscal 2027 revenue to range between $3.585 billion and $3.60 billion, aligning closely... with FactSet estimates of $3.56 billion. This guidance reflects Veeva's strategic positioning in the life sciences industry, leveraging its cloud solutions to drive growth.
Veeva (VEEV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Veeva Systems reported a 16% increase in revenue for Q4 2026, totaling $835.95 million, surpassing analyst expectations. The EPS of $2.06 also exceeded estimates. Subscription services revenue rose b...y 16.3%, driven by Veeva R&D and Commercial Solutions. Despite strong financial performance, Veeva's stock has declined by 2.6% over the past month.
Veeva Announces Fourth Quarter and Fiscal Year 2026 Results
Veeva Systems reported its fiscal year 2026 results, showing a 16% increase in total revenues to $3.195 billion. Subscription revenues rose by 17% to $2.684 billion. The company highlighted strong pe...rformance in its Commercial, Development, and Quality Clouds, with significant customer wins in biopharma. Veeva aims for a $6 billion revenue run rate by 2030, driven by its integrated AI solutions and expanding customer base.
Veeva Systems Fiscal Q4 Non-GAAP Earnings, Revenue Rise; Outlook Issued
Veeva Systems reported an increase in its fiscal Q4 non-GAAP earnings and revenue, and provided an optimistic outlook for the upcoming fiscal year. The company anticipates fiscal 2027 adjusted EPS of... approximately $8.85 and a revenue range of $3.585 billion to $3.60 billion, surpassing FactSet estimates.
Veeva Systems reported a 16% increase in FY26 revenue, reaching $3.2 billion, highlighting significant growth in its industry cloud solutions for life sciences.
Veeva Systems reported a significant increase in its Q4 earnings, with profits rising to $244.20 million, or $1.45 per share, compared to $195.62 million, or $1.18 per share, last year. Adjusted earn...ings were $346.12 million, or $2.06 per share. Revenue increased by 16% to $835.95 million. The company provided guidance for the next quarter, expecting EPS between $2.13 and $2.14 and revenue between $855 million and $858 million.
Veeva Systems reported a Q4 non-GAAP EPS of $2.06, surpassing expectations by $0.12, and achieved a 16% year-over-year revenue increase to $835.95 million. The company projects Q1 FY2026 revenues bet...ween $855 million and $858 million, with updated FY2027 guidance forecasting revenues between $3.585 billion and $3.6 billion, reflecting strong demand for its subscription services.
Veeva Systems under pressure as earnings loom amid CRM competition
Veeva Systems is set to announce its Q4 fiscal 2026 earnings amid competitive pressures from Salesforce in the life sciences CRM market. Analysts expect earnings of $1.93 per share on $810.7 million ...revenue, marking a year-over-year growth but a sequential decline. Investors are keen on Veeva's AI strategy and margin guidance as it competes with Salesforce's AI capabilities and customer acquisitions.
Veeva to Release Fiscal 2026 Fourth Quarter and Full Year Results on March 4, 2026
Veeva Systems will announce its fiscal 2026 fourth quarter and full year financial results on March 4, 2026. The company will host a conference call and webcast to discuss these results.
Veeva Systems (VEEV) Ups Guidance and Highlights AI ProgressIs the ...
Veeva Systems reported strong third-quarter results with revenue of $811.24 million and net income of $236.2 million, surpassing expectations. The company raised its guidance for the fourth quarter a...nd full fiscal year, highlighting significant progress in AI adoption across its product suite. Veeva's AI-driven platforms are enhancing innovation and efficiency for life sciences customers, despite ongoing customer concentration risks.
Leadership and Executive Team Updates at Veeva CRM
Veeva Systems Announces Chief Accounting Officer Resignation - TipRanks.com
Kristine Diamond, Veeva Systems' Chief Accounting Officer, will resign on December 11, 2025. Brian Van Wagener, the CFO, will temporarily assume her role until a successor is appointed.
Corporate News and Organizational Updates on Veeva CRM
Veeva Becomes First Public Company to Convert to a Public Benefit Corporation
Veeva Systems has become the first publicly traded company to convert to a Public Benefit Corporation (PBC), following overwhelming shareholder approval. This transition aligns Veeva's legal charter ...with its mission to balance the interests of customers, employees, partners, and shareholders, supporting its commitment to stakeholder capitalism and long-term value creation.
Veeva Systems Joins S&P 500, Boosting Market Position
Veeva Systems will join the S&P 500 on May 7, replacing Coterra Energy. This inclusion reflects market confidence in Veeva's performance, as evidenced by a stock price increase on May 1. The company ...is also migrating customers to its Vault CRM system, aiming for completion by 2029, which is expected to enhance margins and technical control.
Veeva Systems Inc. has been added to multiple S&P indices, including the S&P 500, S&P 500 Growth, and S&P 500 Health Care indices. This inclusion reflects Veeva's significant role in the health care ...and technology sectors.
